Anna Poma

Prof. Anna Poma


Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
Verified
Journal Article
Closed access
MGMaria Laura Di Giorgio
Maria Laura Di Giorgio
SBSebastiano Di Bucchianico
Sebastiano Di Bucchianico
ARAnna Maria Ragnelli
Anna Maria Ragnelli
PAPierpaolo Aimola
Pierpaolo Aimola
SSSandro Santucci
Sandro Santucci
APAnna Poma
Anna Poma

Verified
Journal Article
Open access
PDF file
LMLaura De Marzi
Laura De Marzi
AMAntonina Monaco
Antonina Monaco
JLJoaquin De Lapuente
Joaquin De Lapuente
DRDavid Ramos
David Ramos
MBMiquel Borras
Miquel Borras
APAnna Poma
Anna Poma
Owing to their radical scavenging and UV-filtering properties, ceria nanoparticles (CeO2-NPs) are currently used for various applications, including as catalysts in diesel particulate filters. Because of their ability to filter UV light, CeO2-NPs have garnered significant interest in the medical field and, consequently, are poised for use in various applications. The aim of this work was to investigate the effects of short-term (24 h) and long-term (10 days) CeO2-NP exposure to A549, CaCo2 and HepG2 cell lines. Cytotoxicity assays tested CeO2-NPs over a concentration range of 0.5 μg/mL to 5000 μg/mL, whereas genotoxicity assays tested CeO2-NPs over a concentration range of 0.5 μg/mL to 5000 μg/mL. In vitro assays showed almost no short-term exposure toxicity on any of the tested cell lines. Conversely, long-term CeO2-NP exposure proved toxic for all tested cell lines. NP genotoxicity was detectable even at 24-h exposure. HepG2 was the most sensitive cell line overall; however, the A549 line was most sensitive to the lowest concentration tested. Moreover, the results confirmed the ceria nanoparticles’ capacity to protect cells when they are exposed to well-known oxidants such as H2O2. A Comet assay was performed in the presence of both H2O2 and CeO2-NPs. When hydrogen peroxide was maintained at 25 μM, NPs at 0.5 μg/mL, 50 μg/mL, and 500 μg/mL protected the cells from oxidative damage. Thus, the NPs prevented H2O2-induced genotoxic damage.

1 September 2012 in Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
APAnna Poma
Anna Poma
GFGabriella Fontecchio
Gabriella Fontecchio
GCGiuseppe Carlucci
Giuseppe Carlucci
GCGiuseppe Chichiricco
Giuseppe Chichiricco
The medicinal uses of saffron (Crocus sativus Linnaeus) have a long history beginning in Asian countries since the Late Bronze Age. Recent studies have validated its potential to lower the risk of several diseases. Some metabolites derived from saffron stigmas exert numerous therapeutic effects due to hypolipidemic, antitussive, antioxidant, antidiabetic activities and many others. Water and ethanol extracts of Crocus sativus L. are cardioprotective and counteract neurodegenerative disorders. Many of these medicinal properties of saffron can be attributed to a number of its compounds such as crocetin, crocins and other substances having strong antioxidant and radical scavenger properties against a variety of radical oxygen species and pro-inflammatory cytokines. Botany, worldwide spreading of cultivars, biochemical pathways, active constituents and chemical detection methods are reviewed. Therapeutic uses of saffron principles with particular regard to those exhibiting antioxidant and thus anti-inflammatory features are discussed. To date, very few adverse health effects of saffron have been demonstrated. At high doses (more than 5 g/die day), it should be avoided in pregnancy owing to its uterine stimulation activity.

27 November 2006 in Microscopy Research and Technique
Verified
Journal Article
Closed access
PDF file
Jozef KaiserJozef Kaiser
Jozef Kaiser
OSOta Samek
Ota Samek
LRL. Reale
L. Reale
MLM. Lis˘kA
M. Lis˘kA
RMRobert Malina
Robert Malina
GCGianfelice Cinque
Gianfelice Cinque

1 October 1999 in Immunopharmacology
Verified
Journal Article
Closed access
MCMarco Carmignani
Marco Carmignani
PBPaolo Boscolo
Paolo Boscolo
APAnna Poma
Anna Poma
AVAnna Rita Volpe
Anna Rita Volpe

1 December 2007 in Spectrochimica Acta Part B: Atomic Spectroscopy
Verified
Journal Article
Closed access
MGM. Galiová
M. Galiová
Jozef KaiserJozef Kaiser
Jozef Kaiser
KNK. Novotný
K. Novotný
OSOta Samek
Ota Samek
LRL. Reale
L. Reale
ATA. Tucci
A. Tucci